, id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,18074,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,10154,Carbonic anhydrase 6,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10154,P23280,Carbonic anhydrase 6,765.0,CA6,9606,Homo sapiens (human),,Ki (nM),11900.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
1,18075,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1361,Carbonic anhydrase 7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1361,P43166,Carbonic anhydrase 7,766.0,CA7,9606,Homo sapiens (human),,Ki (nM),82100.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
2,18267,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1233,Carbonic anhydrase 9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1233,Q16790,Carbonic anhydrase 9,768.0,CA9,9606,Homo sapiens (human),,Ki (nM),78700.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
3,18268,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1363,Carbonic anhydrase 12,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1363,O43570,Carbonic anhydrase 12,771.0,CA12,9606,Homo sapiens (human),,Ki (nM),8800.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
4,18269,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),,Ki (nM),9900.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
5,18270,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,Ki (nM),7100.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
6,18271,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606,Homo sapiens (human),,Ki (nM),11100.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
7,18272,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,2920,Carbonic anhydrase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2920,P07451,Carbonic anhydrase 3,761.0,CA3,9606,Homo sapiens (human),,Ki (nM),885000.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
8,18273,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1228,"Carbonic anhydrase 5A, mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1228,P35218,"Carbonic anhydrase 5A, mitochondrial",763.0,CA5A,9606,Homo sapiens (human),,Ki (nM),678000.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
9,35575,338,Drug Gene Interaction database (DGIdb),Salicylic Acid,,SALICYLIC ACID,https://www.dgidb.org/drugs/rxcui:9525,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606,Homo sapiens (human),,,,,,,,
10,35576,338,IUPHAR/BPS Guide to PHARMACOLOGY,Salicylic Acid,4306,salicylic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4306,686,ASIC3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=686,Q9UHC3,Acid-sensing ion channel 3,9311.0,ASIC3,9606,Homo sapiens (human),,pIC50,3.6,PMID:11588175,https://www.ncbi.nlm.nih.gov/pubmed/11588175,11588175,,
11,35604,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1364,Carbonic anhydrase 13,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1364,Q9D6N1,Carbonic anhydrase 13,71934.0,Car13,10090,Mus musculus (house mouse),,Ki (nM),67000.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
12,35605,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1365,Carbonic anhydrase 14,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1365,Q9ULX7,Carbonic anhydrase 14,23632.0,CA14,9606,Homo sapiens (human),,Ki (nM),49800.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
13,35606,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,1229,"Carbonic anhydrase 5B, mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1229,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",11238.0,CA5B,9606,Homo sapiens (human),,Ki (nM),355000.0,PMID:18579385|DOI:10.1016/j.bmc.2008.06.013,https://www.ncbi.nlm.nih.gov/pubmed/18579385|https://doi.org/10.1016/j.bmc.2008.06.013,18579385,10.1016/j.bmc.2008.06.013,
14,35607,338,Drug Gene Interaction database (DGIdb),Salicylic Acid,,SALICYLIC ACID,https://www.dgidb.org/drugs/rxcui:9525,,PTGS1,https://www.dgidb.org/genes/hgnc:9604,,,5742.0,PTGS1,9606,Homo sapiens (human),,,,,,,,
15,41269,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000017,Prostaglandin G/H synthase 1,https://www.drugbank.ca/bio_entities/BE0000017,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),Inhibitor,,,PMID:15840771|PMID:11752352|PMID:5284360|PMID:14746879|PMID:15871445|PMID:15035793|PMID:16368818,https://www.ncbi.nlm.nih.gov/pubmed/15840771|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/5284360|https://www.ncbi.nlm.nih.gov/pubmed/14746879|https://www.ncbi.nlm.nih.gov/pubmed/15871445|https://www.ncbi.nlm.nih.gov/pubmed/15035793|https://www.ncbi.nlm.nih.gov/pubmed/16368818,15840771|11752352|5284360|14746879|15871445|15035793|16368818,,
16,41270,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000262,Prostaglandin G/H synthase 2,https://www.drugbank.ca/bio_entities/BE0000262,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),Inhibitor,,,PMID:15199473|PMID:17259377|PMID:5284360|PMID:15106733|PMID:15070163|PMID:15348270|PMID:15035793,https://www.ncbi.nlm.nih.gov/pubmed/15199473|https://www.ncbi.nlm.nih.gov/pubmed/17259377|https://www.ncbi.nlm.nih.gov/pubmed/5284360|https://www.ncbi.nlm.nih.gov/pubmed/15106733|https://www.ncbi.nlm.nih.gov/pubmed/15070163|https://www.ncbi.nlm.nih.gov/pubmed/15348270|https://www.ncbi.nlm.nih.gov/pubmed/15035793,15199473|17259377|5284360|15106733|15070163|15348270|15035793,,
17,41271,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000126,Aldo-keto reductase family 1 member C1,https://www.drugbank.ca/bio_entities/BE0000126,Q04828,Aldo-keto reductase family 1 member C1,1645.0,AKR1C1,9606,Homo sapiens (human),Inhibitor,,,PMID:18045204,https://www.ncbi.nlm.nih.gov/pubmed/18045204,18045204,,
18,41272,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606,Homo sapiens (human),Substrate,,,PMID:25840124|PMID:19515014,https://www.ncbi.nlm.nih.gov/pubmed/25840124|https://www.ncbi.nlm.nih.gov/pubmed/19515014,25840124|19515014,,
19,41273,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0001066,Solute carrier family 22 member 6,https://www.drugbank.ca/bio_entities/BE0001066,Q4U2R8,Solute carrier family 22 member 6,9356.0,SLC22A6,9606,Homo sapiens (human),Inhibitor,,,PMID:10929807|PMID:12130730|PMID:11099697|PMID:10220563|PMID:10049739,https://www.ncbi.nlm.nih.gov/pubmed/10929807|https://www.ncbi.nlm.nih.gov/pubmed/12130730|https://www.ncbi.nlm.nih.gov/pubmed/11099697|https://www.ncbi.nlm.nih.gov/pubmed/10220563|https://www.ncbi.nlm.nih.gov/pubmed/10049739,10929807|12130730|11099697|10220563|10049739,,
20,41517,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0003652,Solute carrier family 22 member 10,https://www.drugbank.ca/bio_entities/BE0003652,Q63ZE4,Solute carrier family 22 member 10,387775.0,SLC22A10,9606,Homo sapiens (human),Inhibitor,,,PMID:15068970,https://www.ncbi.nlm.nih.gov/pubmed/15068970,15068970,,
21,41518,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0003645,Solute carrier family 22 member 8,https://www.drugbank.ca/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606,Homo sapiens (human),Inhibitor,,,PMID:14762099|PMID:11306713|PMID:12130730,https://www.ncbi.nlm.nih.gov/pubmed/14762099|https://www.ncbi.nlm.nih.gov/pubmed/11306713|https://www.ncbi.nlm.nih.gov/pubmed/12130730,14762099|11306713|12130730,,
22,41519,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000879,Solute carrier family 22 member 11,https://www.drugbank.ca/bio_entities/BE0000879,Q9NSA0,Solute carrier family 22 member 11,55867.0,SLC22A11,9606,Homo sapiens (human),Inhibitor,,,PMID:10660625,https://www.ncbi.nlm.nih.gov/pubmed/10660625,10660625,,
23,41520,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0001042,Solute carrier organic anion transporter family member 2B1,https://www.drugbank.ca/bio_entities/BE0001042,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606,Homo sapiens (human),Substrate,,,PMID:15640378,https://www.ncbi.nlm.nih.gov/pubmed/15640378,15640378,,
24,41521,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000669,Monocarboxylate transporter 1,https://www.drugbank.ca/bio_entities/BE0000669,P53985,Monocarboxylate transporter 1,6566.0,SLC16A1,9606,Homo sapiens (human),Substrate,,,PMID:10579682,https://www.ncbi.nlm.nih.gov/pubmed/10579682,10579682,,
25,41522,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0003646,Solute carrier family 22 member 7,https://www.drugbank.ca/bio_entities/BE0003646,Q9Y694,Solute carrier family 22 member 7,10864.0,SLC22A7,9606,Homo sapiens (human),Substrate,,,PMID:9650585|PMID:11504818|PMID:12065749,https://www.ncbi.nlm.nih.gov/pubmed/9650585|https://www.ncbi.nlm.nih.gov/pubmed/11504818|https://www.ncbi.nlm.nih.gov/pubmed/12065749,9650585|11504818|12065749,,
26,41523,338,DrugBank,Salicylic Acid,DB00936,Salicylic acid,https://www.drugbank.ca/drugs/DB00936,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606,Homo sapiens (human),Other/unknown,,,PMID:15819089|PMID:15768982|PMID:17320187|PMID:9275312,https://www.ncbi.nlm.nih.gov/pubmed/15819089|https://www.ncbi.nlm.nih.gov/pubmed/15768982|https://www.ncbi.nlm.nih.gov/pubmed/17320187|https://www.ncbi.nlm.nih.gov/pubmed/9275312,15819089|15768982|17320187|9275312,,
27,54679,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in decreased expression of ADIPOQ mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
28,54680,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606,Homo sapiens (human),Salicylic acid inhibits the reaction [AKR1C1 protein results in decreased susceptibility to cisplatin]|benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [salicylic acid inhibits the reaction [AKR1C1 protein results in decreased susceptibility to cisplatin]],,,PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/23165153,23165153,,
29,54681,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606,Homo sapiens (human),Salicylic acid results in decreased activity of AKR1C1 protein,,,PMID:19010312|PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/19010312|https://www.ncbi.nlm.nih.gov/pubmed/23165153,19010312|23165153,,
30,54682,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606,Homo sapiens (human),Salicylic acid results in decreased activity of AKR1C2 protein,,,PMID:19010312,https://www.ncbi.nlm.nih.gov/pubmed/19010312,19010312,,
31,54683,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606,Homo sapiens (human),Salicylic acid results in increased expression of AKR1C2 mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
32,54684,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606,Homo sapiens (human),Salicylic acid results in decreased activity of AKR1C3 protein,,,PMID:19010312,https://www.ncbi.nlm.nih.gov/pubmed/19010312,19010312,,
33,54685,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,383,ARG1,https://ctdbase.org/detail.go?type=gene&acc=383,,,383.0,ARG1,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in decreased expression of ARG1 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
34,54686,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,7955,Danio rerio (zebrafish),[teratogens results in increased abundance of salicylic acid] which results in increased expression of CASP3 protein,,,PMID:37531284,https://www.ncbi.nlm.nih.gov/pubmed/37531284,37531284,,
35,54687,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
36,54688,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of CCL2 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
37,54882,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090,Mus musculus (house mouse),Salicylic acid results in increased expression of CXCL2 protein,,,PMID:23178550,https://www.ncbi.nlm.nih.gov/pubmed/23178550,23178550,,
38,54883,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CXCL8 protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
39,54884,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Salicylic acid results in increased expression of CXCL8 protein,,,PMID:31734321,https://www.ncbi.nlm.nih.gov/pubmed/31734321,31734321,,
40,54885,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,1579,CYP4A11,https://ctdbase.org/detail.go?type=gene&acc=1579,,,1579.0,CYP4A11,9606,Homo sapiens (human),Salicylic acid affects the activity of CYP4A11 protein,,,PMID:37499995,https://www.ncbi.nlm.nih.gov/pubmed/37499995,37499995,,
41,54886,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Potassium chloride affects the reaction [salicylic acid affects the expression of ICAM1 protein]|salicylic acid affects the expression of ICAM1 protein,,,PMID:30842373,https://www.ncbi.nlm.nih.gov/pubmed/30842373,30842373,,
42,54887,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
43,54888,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090,Mus musculus (house mouse),Salicylic acid results in increased expression of IL1A protein,,,PMID:23178550,https://www.ncbi.nlm.nih.gov/pubmed/23178550,23178550,,
44,54889,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Salicylic acid results in increased expression of IL1B protein,,,PMID:30842373,https://www.ncbi.nlm.nih.gov/pubmed/30842373,30842373,,
45,54890,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,9606,Homo sapiens (human),Salicylic acid results in decreased expression of IL4 mrna|salicylic acid results in decreased secretion of IL4 protein,,,PMID:11238116,https://www.ncbi.nlm.nih.gov/pubmed/11238116,11238116,,
46,54891,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Salicylic acid inhibits the reaction [mercury results in increased expression of IL6],,,PMID:23742082,https://www.ncbi.nlm.nih.gov/pubmed/23742082,23742082,,
47,55195,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of IL6 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
48,55196,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4025,LPO,https://ctdbase.org/detail.go?type=gene&acc=4025,,,4025.0,LPO,9913,Bos taurus (cattle),Salicylic acid results in decreased activity of LPO protein,,,PMID:28594102,https://www.ncbi.nlm.nih.gov/pubmed/28594102,28594102,,
49,55197,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606,Homo sapiens (human),Salicylic acid results in increased expression of MAFF mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
50,55198,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),Salicylic acid results in increased activity of MPO protein,,,PMID:24060682,https://www.ncbi.nlm.nih.gov/pubmed/24060682,24060682,,
51,55199,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4489,MT1A,https://ctdbase.org/detail.go?type=gene&acc=4489,,,4489.0,MT1A,9606,Homo sapiens (human),Salicylic acid results in increased expression of MT1A mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
52,55200,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of NOS2 mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
53,55201,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid inhibits the reaction [acetylcholine results in increased phosphorylation of NOS3 protein]],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
54,55202,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in decreased expression of PPARG mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
55,55203,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,9606,Homo sapiens (human),Salicylic acid results in increased expression of PSMB10 mRNA,,,PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/23165153,23165153,,
56,55204,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,9606,Homo sapiens (human),Salicylic acid results in increased expression of PSMB9 mRNA,,,PMID:23165153,https://www.ncbi.nlm.nih.gov/pubmed/23165153,23165153,,
57,55449,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Salicylic acid results in decreased expression of PTGS2 mRNA,,,PMID:16936242,https://www.ncbi.nlm.nih.gov/pubmed/16936242,16936242,,
58,55450,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]|niacinamide inhibits the reaction [salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|dorsomorphin inhibits the reaction [salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
59,55451,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to salicylic acid,,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
60,55452,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,9606,Homo sapiens (human),Salicylic acid inhibits the reaction [SLC16A1 protein results in increased uptake of lactic acid],,,PMID:15804185,https://www.ncbi.nlm.nih.gov/pubmed/15804185,15804185,,
61,55453,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [SLC16A1 protein results in increased transport of benzoic acid],,,PMID:10714609,https://www.ncbi.nlm.nih.gov/pubmed/10714609,10714609,,
62,55454,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,55867,SLC22A11,https://ctdbase.org/detail.go?type=gene&acc=55867,,,55867.0,SLC22A11,9606,Homo sapiens (human),Salicylic acid results in decreased activity of SLC22A11 protein|slc22a11 protein results in increased uptake of salicylic acid,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
63,55455,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,171405,SLC22A27,https://ctdbase.org/detail.go?type=gene&acc=171405,,,171405.0,Slc22a27,10090,Mus musculus (house mouse),SLC22A27 protein alternative form results in increased transport of salicylic acid|salicylic acid inhibits the reaction [SLC22A27 protein alternative form results in increased uptake of carnitine],,,PMID:20332632,https://www.ncbi.nlm.nih.gov/pubmed/20332632,20332632,,
64,55456,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,9356,SLC22A6,https://ctdbase.org/detail.go?type=gene&acc=9356,,,9356.0,SLC22A6,9606,Homo sapiens (human),Salicylic acid results in decreased activity of SLC22A6 protein|slc22a6 protein results in increased uptake of salicylic acid,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
65,55457,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,10864,SLC22A7,https://ctdbase.org/detail.go?type=gene&acc=10864,,,10864.0,SLC22A7,9606,Homo sapiens (human),Salicylic acid promotes the reaction [SLC22A7 protein results in increased export of orotic acid],,,PMID:22981274,https://www.ncbi.nlm.nih.gov/pubmed/22981274,22981274,,
66,55458,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,10864,SLC22A7,https://ctdbase.org/detail.go?type=gene&acc=10864,,,10864.0,SLC22A7,9606,Homo sapiens (human),Salicylic acid results in decreased activity of SLC22A7 protein|slc22a7 protein results in increased uptake of salicylic acid,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
67,55710,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,114571,SLC22A9,https://ctdbase.org/detail.go?type=gene&acc=114571,,,114571.0,SLC22A9,9606,Homo sapiens (human),SLC22A9 protein results in increased uptake of salicylic acid|salicylic acid results in decreased activity of SLC22A9 protein,,,PMID:12388633,https://www.ncbi.nlm.nih.gov/pubmed/12388633,12388633,,
68,55711,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid results in decreased expression of STAR mRNA,,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
69,55712,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),"Salicylic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]",,,PMID:36416909,https://www.ncbi.nlm.nih.gov/pubmed/36416909,36416909,,
70,55713,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Salicylic acid inhibits the reaction [palmitic acid results in increased expression of TNF mrna],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
71,55714,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid results in decreased expression of TSPO mRNA,,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
72,55715,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7295,TXN,https://ctdbase.org/detail.go?type=gene&acc=7295,,,7295.0,TXN,9606,Homo sapiens (human),Salicylic acid results in increased expression of TXN mRNA,,,PMID:20491607,https://www.ncbi.nlm.nih.gov/pubmed/20491607,20491607,,
73,55716,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575.0,UGT1A10,9606,Homo sapiens (human),UGT1A10 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
74,55717,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54659,UGT1A3,https://ctdbase.org/detail.go?type=gene&acc=54659,,,54659.0,UGT1A3,9606,Homo sapiens (human),UGT1A3 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
75,55718,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577.0,UGT1A7,9606,Homo sapiens (human),UGT1A7 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
76,55719,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,54576,UGT1A8,https://ctdbase.org/detail.go?type=gene&acc=54576,,,54576.0,UGT1A8,9606,Homo sapiens (human),UGT1A8 protein results in increased glucuronidation of salicylic acid,,,PMID:15117964,https://www.ncbi.nlm.nih.gov/pubmed/15117964,15117964,,
77,55914,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9606,Homo sapiens (human),Salicylic acid inhibits the reaction [XDH protein results in increased abundance of reactive oxygen species],,,PMID:3840323,https://www.ncbi.nlm.nih.gov/pubmed/3840323,3840323,,
78,55915,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,9311,ASIC3,https://ctdbase.org/detail.go?type=gene&acc=9311,,,9311.0,ASIC3,10116,Rattus norvegicus (Norway rat),Salicylic acid results in decreased activity of ASIC3 protein,,,PMID:11588175,https://www.ncbi.nlm.nih.gov/pubmed/11588175,11588175,,
79,58582,338,Drug Gene Interaction database (DGIdb),Salicylic Acid,,SALICYLIC ACID,https://www.dgidb.org/drugs/rxcui:9525,,PTGS1,https://www.dgidb.org/genes/hgnc:9604,,,5742.0,PTGS1,9606,Homo sapiens (human),,,,,,,,
80,58583,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid inhibits the reaction [POMC protein results in increased abundance of hydrocortisone],,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
81,65975,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T06569,Carbonic anhydrase VI (CA-VI),https://idrblab.net/ttd/data/target/details/T06569,P23280,Carbonic anhydrase 6,765.0,CA6,9606,Homo sapiens (human),Inhibitor,,,,,,,
82,65976,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T16987,Carbonic anhydrase XII (CA-XII),https://idrblab.net/ttd/data/target/details/T16987,O43570,Carbonic anhydrase 12,771.0,CA12,9606,Homo sapiens (human),Inhibitor,,,,,,,
83,65977,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),Inhibitor,,,,,,,
84,65978,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T53378,Carbonic anhydrase IV (CA-IV),https://idrblab.net/ttd/data/target/details/T53378,P22748,Carbonic anhydrase 4,762.0,CA4,9606,Homo sapiens (human),Inhibitor,,,,,,,
85,66160,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),Inhibitor,,,,,,,
86,66161,338,Therapeutic Target Database (TTD),Salicylic Acid,D07HBX,Salicyclic acid,https://idrblab.net/ttd/data/drug/details/D07HBX,T60529,Prostaglandin G/H synthase 1 (COX-1),https://idrblab.net/ttd/data/target/details/T60529,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),Inhibitor,,,,,,,
87,66162,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,8022,Oncorhynchus mykiss (rainbow trout),Salicylic acid results in decreased expression of NR3C1 protein,,,PMID:16551645,https://www.ncbi.nlm.nih.gov/pubmed/16551645,16551645,,
88,66163,338,Comparative Toxicogenomics Database (CTD),Salicylic Acid,D020156,Salicylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D020156,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606,Homo sapiens (human),Salicylic acid results in increased phosphorylation of CASP1 protein,,,PMID:30842373,https://www.ncbi.nlm.nih.gov/pubmed/30842373,30842373,,
89,82974,338,BindingDB,Salicylic Acid,26193,"2-Hydroxybenzoate, I",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26193,5270,Prolyl 4-hydroxylase subunit alpha-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5270,P16924,Prolyl 4-hydroxylase subunit alpha-1,,,9031,Gallus gallus (chicken),,Ki (nM),2300000.0,PMID:3011801,https://www.ncbi.nlm.nih.gov/pubmed/3011801,3011801,,
90,83711,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000017,Prostaglandin G/H synthase 1,http://www.t3db.ca/biodb/bio_entities/BE0000017,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),,,,PMID:11752352|PMID:14746879|PMID:15035793|PMID:15840771|PMID:15871445|PMID:16368818|PMID:5284360,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/14746879|https://www.ncbi.nlm.nih.gov/pubmed/15035793|https://www.ncbi.nlm.nih.gov/pubmed/15840771|https://www.ncbi.nlm.nih.gov/pubmed/15871445|https://www.ncbi.nlm.nih.gov/pubmed/16368818|https://www.ncbi.nlm.nih.gov/pubmed/5284360,11752352|14746879|15035793|15840771|15871445|16368818|5284360,,
91,83712,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000262,Prostaglandin G/H synthase 2,http://www.t3db.ca/biodb/bio_entities/BE0000262,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),,,,PMID:15035793|PMID:5284360|PMID:15070163|PMID:15106733|PMID:15199473|PMID:15348270,https://www.ncbi.nlm.nih.gov/pubmed/15035793|https://www.ncbi.nlm.nih.gov/pubmed/5284360|https://www.ncbi.nlm.nih.gov/pubmed/15070163|https://www.ncbi.nlm.nih.gov/pubmed/15106733|https://www.ncbi.nlm.nih.gov/pubmed/15199473|https://www.ncbi.nlm.nih.gov/pubmed/15348270,15035793|5284360|15070163|15106733|15199473|15348270,,
92,83713,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000126,Aldo-keto reductase family 1 member C1,http://www.t3db.ca/biodb/bio_entities/BE0000126,Q04828,Aldo-keto reductase family 1 member C1,1645.0,AKR1C1,9606,Homo sapiens (human),,,,PMID:18045204,https://www.ncbi.nlm.nih.gov/pubmed/18045204,18045204,,
93,83714,338,Toxin and Toxin Target Database (T3DB),Salicylic Acid,T3D4816,Salicylic acid,http://www.t3db.ca/toxins/T3D4816,BE0000132,Androgen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000132,P10275,Androgen receptor,367.0,AR,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
94,83715,338,Drug Gene Interaction database (DGIdb),Salicylic Acid,,SALICYLIC ACID,https://www.dgidb.org/drugs/rxcui:9525,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606,Homo sapiens (human),,,,,,,,
